CanCaN 2021
Welcome!
CanCaN 2021 is a conference on cancer, cardiovascular diseases, and neurological disorders organized by the PhD students of the Research Training Group 2381 (GRK 2381: “cGMP: From Bedside to Bench”) at the University of Tübingen. The aim is to provide a platform for young scientists to learn from experts in the field as well as exchange information about the current state of research on these topics. The GRK started in July 2019 with the goal of investigating the role of the second messenger molecule cGMP in healthy and disease states in multiple cell- and tissue-types. Therefore, CanCaN 2021 will cover a broad spectrum of topics presented by speakers from basic and clinical science as well as pharmaceutical industries.
The conference will be held in a hybrid format, with the opportunity for an in-person and an online audience to join us in Tübingen. We are looking forward to welcoming you!
Your Organization Team
Mariagiovanna Barresi, Alexandra Böttcher, and Malte Roeßing
Poster Abstracts
How to find us.
Downloads
Supported by
Confirmed speakers
We are delighted to announce a wide range of international speakers, that will present an interesting and diverse main program.
Dmitriy Atochin, MD, PhD
Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School
PD Dr. Christian Becker
Department of Dermatology, University Hospital Münster
Prof. Dr. Moritz Bünemann
Institute of Pharmacology and Clinical Pharmacy, Philipps-University Marburg
Prof. Dr. Ingrid Ehrlich
Institute of Biomaterials and Biomolecular Systems, University of Stuttgart
Prof. Dr. Andreas Friebe
Institute of Physiology, University of Würzburg
Dai Fukumura, MD, PhD
Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School
Dr. Christine Gee
Institute of Synaptic Physiology, University Medical Center Hamburg-Eppendorf
Clint Makino, PhD
Department of Physiology and Biophysics, Boston University School of Medicine
Dr. Thomas Müller
Department of Cell Biology, Bayer AG
Prof. Dr. Viacheslav Nikolaev
Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf
Prof. Dr. Stefan Offermanns
Department of Pharmacology, Max Planck Institute for Heart and Lung Research
Prof. Dr. Monilola Olayioye
Institute of Cell Biology and Immunology, University of Stuttgart
Prof. Dr. François Paquet-Durand
Institute for Ophthalmic Research, University of Tübingen
Dr. habil. Verena Raker
Department of Dermatology, University Hospital Münster
Prof. Dr. Peter Sandner
Research and Development Pharmaceuticals, Bayer AG
Prof. Dr. Harald Schmidt
Department of Pharmacology and Personalised Medicine, Maastricht University
Prof. Dr. Dr. Achim Schmidtko
Department Pharmacology for Science Students, Goethe University
Gregory Schwartz, PhD
Department of Ophthalmology, Northwestern University
Prof. Dr. Gil Westmeyer
Department of Chemistry and School of Medicine, Technical University of Munich
Maria Zaldivia, PhD
Interfaculty Institute of Biochemistry, University of Tübingen
Location
Hybrid event
Alte Aula Eberhard Karls Universität Tübingen
30, Münzgasse Tübingen, BW Germany, 72070Contact us
If you have any questions, please contact grk2381@mnf.uni-tuebingen.de .
